Dwarfism and early death in mice lacking C-type natriuretic peptide

被引:353
|
作者
Chusho, H
Tamura, N
Ogawa, Y [1 ]
Yasoda, A
Suda, M
Miyazawa, T
Nakamura, K
Nakao, K
Kurihara, T
Komatsu, Y
Itoh, H
Tanaka, K
Saito, Y
Katsuki, M
Nakao, K
机构
[1] Kyoto Univ, Sch Med, Dept Med & Clin Sci, Kyoto 6068507, Japan
[2] Suntory Inst Biomed Res, Shimamoto, Osaka 6180024, Japan
[3] Univ Tokyo, Inst Med Sci, Lab Anim Res Ctr, Tokyo 1080071, Japan
关键词
D O I
10.1073/pnas.071389098
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Longitudinal bone growth is determined by endochondral ossification that occurs as chondrocytes in the cartilaginous growth plate undergo proliferation, hypertrophy, cell death, and osteoblastic replacement. The natriuretic peptide family consists of three structurally related endogenous ligands, atrial, brain, and C-type natriuretic peptides (ANP, BNP, and CNP), and is thought to be involved in a variety of homeostatic processes. To investigate the physiological significance of CNP in vivo, we generated mice with targeted disruption of CNP (Nppc(-/-) mice). The Nppc(-/-) mice show severe dwarfism as a result of impaired endochondral ossification. They are all viable perinatally, but less than half can survive during postnatal development. The skeletal phenotypes are histologically similar to those seen in patients with achondroplasia, the most common genetic form of human dwarfism. Targeted expression of CNP in the growth plate chondrocytes can rescue the skeletal defect of Nppc(-/-) mice and allow their prolonged survival. This study demonstrates that CNP acts locally as a positive regulator of endochondral ossification in vivo and suggests its pathophysiological and therapeutic implication in some forms of skeletal dysplasia.
引用
收藏
页码:4016 / 4021
页数:6
相关论文
共 50 条
  • [1] Increased cardiac responsiveness to C-type natriuretic peptide in mice lacking GC-A
    Kuhn, M
    Gambaryan, S
    Lohmann, S
    Schmitz, W
    Boknik, P
    FASEB JOURNAL, 2001, 15 (04): : A230 - A230
  • [2] Accelerated Atherogenesis and Diminished Vascular Integrity in Mice Lacking Endothelial C-Type Natriuretic Peptide
    Moyes, Amie J.
    Khambata, Rayomand S.
    Ahluwalia, Amrita
    Hobbs, Adrian J.
    CIRCULATION, 2012, 126 (21)
  • [3] Targeted overexpression of C-type natriuretic peptide in chondrocytes rescues dwarfism in achondroplasia
    Komatsu, Y
    Yasoda, A
    Chusho, H
    Miyazawa, T
    Ozasa, A
    Miura, M
    Suda, M
    Tamura, N
    Ogawa, Y
    Nakao, K
    BONE, 2003, 32 (05) : S81 - S81
  • [4] C-type natriuretic peptide
    Barr, CS
    Rhodes, P
    Struthers, AD
    PEPTIDES, 1996, 17 (07) : 1243 - 1251
  • [5] C-type natriuretic peptide
    Ruskoaho, H.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2008, 102 : 10 - 10
  • [6] Reduced ability of C-type natriuretic peptide (CNP) to activate natriuretic peptide receptor B (NPR-B) causes dwarfism in lbab-/- mice
    Yoder, Andrea R.
    Kruse, Andrew C.
    Earhart, Cathleen A.
    Ohlendorf, Douglas H.
    Potter, Lincoln R.
    PEPTIDES, 2008, 29 (09) : 1575 - 1581
  • [7] C-type natriuretic peptide in sepsis
    Mitaka, C
    Hirata, Y
    Sato, K
    Nagura, T
    Tsunoda, Y
    Amaha, K
    INTENSIVE CARE MEDICINE, 1997, 23 (03) : 354 - 355
  • [8] Mismeasure of C-type natriuretic peptide
    Nielsen, Soeren Junge
    Rehfeld, Jens F.
    Goetze, Jens Peter
    CLINICAL CHEMISTRY, 2008, 54 (01) : 225 - 227
  • [9] Urinary C-Type Natriuretic Peptide
    Zakeri, Rosita
    Sangaralingham, S. Jeson
    Sandberg, Sharon M.
    Heublein, Denise M.
    Scott, Christopher G.
    Burnett, John C., Jr.
    JACC-HEART FAILURE, 2013, 1 (02) : 170 - 177
  • [10] C-Type Natriuretic Peptide and Overgrowth
    Bocciardi, Renata
    Ravazzolo, Roberto
    ENDOCRINE INVOLVEMENT IN DEVELOPMENTAL SYNDROMES, 2009, 14 : 61 - 66